Cantor Fitzgerald Initiates Coverage On Immunic with Overweight Rating
Benzinga Newsdesk 4 weeks ago
Analyst RatingsNewsInitiation
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Cantor Fitzgerald analyst Yanni Souroutzidis initiates coverage on Immunic (NASDAQ:IMUX) with a Overweight rating.
Cantor Fitzgerald analyst Yanni Souroutzidis initiates coverage on Immunic (NASDAQ:IMUX) with a Overweight rating.
